Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Posts 6-Percent Rise in Q3 Revenue as Profit Soars 31 Percent

NEW YORK (GenomeWeb News) — Beckman Coulter today said that third-quarter revenue increased 6.1 percent as profits jumped 31 percent.
 
Total receipts for the three months ended Sept. 30 increased to $631.2 million from $593.4 million year over year.
 
Beckman Coulter attributed the good numbers to increased revenues on consumables, particularly in Europe and, to a lesser extent, in the Far East.
 
R&D costs in the quarter increased 57 percent to $81 million year over year.
 
Net income for the quarter was up to $47.5 million, compared with $36.2 million during the same period last year.
 
Beckman Coulter said it had around $69.1 million in current cash and cash equivalents as of Sept. 30.
 
The company maintained it expects steady revenue growth of between 7 percent and 9 percent the fourth quarter of 2006, and for all of 2007.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.